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Summary 
 
Malaria is an extensive global health issue with high morbidity and mortality. Diagnostics of 
malaria are challenging. Clinically malaria is indistinguishable from various other infectious 
diseases. Microscopy of blood smears has generally been considered the gold standard for 
malaria diagnostics. Rapid diagnostic tests (RDTs) and PCR are being used increasingly and 
may prove to be superior alternatives to microscopy, which has many limitations. However, 
microscopy will likely never be entirely replaced by any other method, as it is ideal for 
species identification, quantifying parasitemia and following response to treatment.  
In this study routine and research malaria microscopy, PCR and RDTs for malaria diagnostics 
were compared. PCR detected the most cases. Positive RDT was associated with symptoms of 
severe malaria. Routine malaria microscopy performed poorly and was only confirmed in 43-
53% of cases depending on choice of reference method. A strong association was found 
between anemia and thrombocytopenia and positive malaria results. In addition, palmar pallor 
and evaluation of severity of palmar pallor corresponded well with hemoglobin level.  
 
No asymptomatic malaria was found among 108 young children recruited at a health clinic in 
Dar es Salaam when tested with RDT and PCR of DNA extracted from dried blood spots on 
filter paper (DBS). 
 
Several DNA extraction methods from DBS were tested on a dilution series of a standardized 
Plasmodium positive sample and most performed similarly. However, the method using 
Chelex-100® and soaking of DBS punches in saponin overnight proved to be the method 
with the lowest limit of detection without missing any dilutions. This is also a method that has 
been used in many other studies. A TE-buffer based method performed much poorer than 
expected based on a previous study.  
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PCR done on DBS detected only approximately 54% of cases positive by whole blood PCR. 
This was much lower than in previous studies. All cases positive on PCR of DNA extracted 
from DBS were also positive by RDT and by Plasmodium falciparum species-specific PCR. 
This confirms that it is likely that PCR of DBS detected the cases with highest parasitemia.  
 
The results of these studies support the use of RDTs for routine diagnostics where this is 
possible and when it is unnecessary to follow the effect of treatment or consider 
recrudescence, as routine microscopy performed poorly. Further studies are recommended to 
study asymptomatic malaria in a broader age group and a larger study population. Also, more 
studies comparing PCR of DNA extracted from DBS and whole blood should be done to 
assess whether the results of this study are representative. DBS have become popular to use in 
research settings in rural areas and where transport is difficult and should be evaluated to 
determine whether they truly perform as poorly as this study showed. Using Chelex-100® 
along with soaking in saponin overnight appears to be a good method for extracting DNA 
from DBS.   
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1. BACKGROUND 
1.1 Malaria epidemiology 
Malaria was endemic in 99 countries in 2010 [1], most of these being low-income countries. 
It was estimated that approximately 3.3 billion people were at risk of malaria in 2011 and in 
2010 an estimated 660,000 to 1.2 million people died from malaria [2, 3]. Eighty percent of 
malaria cases and ninety percent of malaria deaths are estimated to occur in Africa with 
young children and pregnant women being the most severely affected [2].  
 
The dominant Plasmodium species in East-Africa is Plasmodium falciparum [4]. Plasmodium 
vivax transmission is widely distributed globally, and dominates in highly populated 
malarious areas outside Africa [5-7]. P. falciparum is considered to be the most deadly of the 
five malaria species [8](P. falciparum, P. vivax, Plasmodium ovale, Plasmodium malariae, 
Plasmodium knowlesi) though infections with P. vivax and P. knowlesi also can be fatal with 
various severe manifestations [7, 9-11]. P. knowlesi and P. malariae are difficult to 
distinguish microscopically, however P. knowlesi generally has more serious presentation and 
can be fatal as opposed to the benign P. malariae infection [11]. The case fatality rate of P. 
knowlesi infection as reported in a review by Antinori et al was 3.4% [12] while P. 
falciparum has a case fatality rate of up to nearly 15% in severe malaria cases depending on 
how promptly treatment is given and the treatments effectiveness [8]. An estimated 98% of 
malaria cases in Africa were due to P. falciparum in 2010 [2] and the disease causes extensive 
morbidity worldwide.  
 
Malaria is a vector-borne disease that is transferred by certain anopheline species of 
mosquitoes [8]. One of the greatest challenges in malaria elimination is vector control. The 
number of malaria cases and deaths have been falling the past decade [3, 4] and between 1945 
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and 2010 seventy-nine countries eliminated malaria [1]. This was likely due to increased 
distribution and use of insecticide-treated nets and indoor residual spraying, along with more 
precise diagnostics and treatment with effective and appropriate antimalarials as a result of 
increased malaria-funding globally and in the most affected nations. Malaria remains a large 
global health concern despite current and previous eradication efforts. Limitations that have 
contributed to counteract eradication efforts include resistance to insecticides and antimalarial 
drugs and limitations in funding as well as lacking environmental and economic development 
in affected countries. Efforts to eliminate malaria can cause a large reduction in malaria cases 
and deaths, but if the pressure of the efforts is reduced when the burden of malaria decreases 
this may lead to a resurgence of the disease [13]. 
 
 Older antimalarials are no longer in use in many areas because of resistance. The effective 
recommended antimalarial treatment with artemisinin combination therapy (ACT) has 
become somewhat threatened by reports of developing resistance to artemisinin compounds in 
the Cambodia-Thailand area [14, 15]. Resistance to artemisinin has not yet been reported in 
sub-Saharan Africa but with resistance found in Asia, precise diagnostics and treatment are 
critical to preserve its effectiveness in other areas. The newer antimalarials are more 
expensive than previous traditional antimalarials such as chloroquine. The high cost of 
treatment further underlines the importance of precise diagnostics and less presumptive 
treatment of unproven malaria to avoid the large expense of overtreatment [16, 17]. 
 
1.2 Diagnostic methods 
Precise malaria diagnostics are important to avoid misdiagnosis of malaria, which can result 
in lacking treatment of an alternative cause of symptoms, or alternatively overdiagnosis and -
treatment of malaria contributing to developing antimalarial resistance. Various methods are 




 
discussed below. A newer method, called loop-mediated isothermal amplification (LAMP), 
was not tested in these studies but recent studies have suggested it may be a promising 
method for performing molecular diagnostics under field conditions. Compared to PCR, 
which is the more frequently used molecular method, it is a simpler, less expensive and time-
consuming method with lower risk of contamination [18].  
 
1.2.1 Clinical diagnosis 
Diagnostics of malaria based on clinical presentation alone, without parasitological 
confirmation, is common practice to identify malaria cases especially in areas with high 
transmission [19]. However, clinically malaria presents elusively. The main symptom, fever, 
is common in a multitude of infectious diseases and other malaria symptoms such as 
vomiting, diarrhea, malaise and tachycardia are also common in other diseases [5, 20, 21]. 
Several other serious infections, including sepsis, typhoid fever, rickettsioses, louse- and tick-
borne relapsing fevers, dengue and other arbovirus infections mimic the presentation of 
severe malaria but require fundamentally different treatment. Previously the WHO 
recommended treating all febrile children in malaria-endemic areas, with no other apparent 
cause of fever than malaria, with antimalarials without parasitological confirmation [22]. 
However, empirical treatment on mere clinical assessment results in vast overtreatment due to 
overdiagnosis of malaria [16, 19]. A study done in Uganda by Opoka et al showed that there 
was increased mortality among patients who received a clinical diagnosis of malaria as 
opposed to those with blood microscopy confirmed malaria [23]. From 2010 WHO changed 
their recommendation to that all cases of malaria be confirmed by a parasitological diagnosis 
before treatment, if possible [24]. As a result of this changed WHO-recommendation there 
has been a recent increase in the use of rapid diagnostic tests (RDTs) for malaria, especially in 
the African region [2, 20].  
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Simple blood tests such as hemoglobin and thrombocyte count are useful to support clinical 
suspicion of malaria with both anemia and thrombocytopenia being common in malaria cases 
[25, 26]. Anemia is a common complication of malaria as a result of increased destruction of 
red blood cells (RBCs) and decreased RBC production and is often a sensitive, though much 
less specific, indicator of malaria in a febrile child in a malaria-endemic area [27, 28]. Many 
explanations of the pathogenesis of thrombocytopenia during malarial infection have been 
proposed and it is likely a complex process [26]. The combination of anemia and 
thrombocytopenia has proved to be fairly sensitive (80%) and specific (84%) for predicting 
malaria [25, 27]. 
 
1.2.2 Blood smear microscopy 
Malaria was identified in a microscope for the first time by a French physician, Alphonse 
Laveran, in Algeria in 1880 [29]. The traditional diagnostic method for malaria has been light 
microscopy of Giemsa-stained blood smears since the early 1900s [30] and blood smear 
microscopy has long been considered the gold-standard for malaria diagnosis [31].  
 
Microscopy has many advantages over other diagnostic methods, as it allows for species 
identification and quantification of parasitemia. As opposed to RDTs and PCR, microscopy 
can identify recrudescence and early reinfections. Microscopy is also useful to monitor the 
reduction of parasitemia quantitatively during treatment and is thus important in diagnostics 
and follow-up. There are disadvantages of using blood smear microscopy; artifacts from the 
staining solutions or from contaminants, as well as thrombocytes can be mistaken for being 
malaria parasites [32]. In a busy and low-resource clinical setting with poor equipment and 
sometimes insufficiently trained lab personnel [33, 34], malaria is often highly over- and 
misdiagnosed by microscopy [34, 35]. Underdiagnosis is also common as only a small 
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volume of blood is viewed during malaria microscopy and low parasitemia may therefore be 
overlooked resulting in false negatives [30, 36]. In addition, differentiating malaria species 
and identifying mixed infections can be difficult by microscopy [37-39]. The expected 
threshold for detection of malaria parasitemia using thick blood smear microscopy is 
approximately 10-50 p/l [31, 40] or higher than 100 p/l under field conditions [30, 31, 41]. 
Highly skilled and experienced technicians may detect levels of parasitemia as low as 5-10 
p/l [41]. With its many limitations the role of blood smear microscopy as a gold standard in 
malaria diagnostics is being called into question [42-44].  
 
1.2.3 Rapid diagnostic tests (RDTs) 
RDTs are being used increasingly and have been implemented in many countries. They are 
recommended by the WHO as routine diagnostics for malaria in areas where microscopy is 
unavailable or unreliable [24]. In Tanzania, studies have shown that the use of RDTs reduces 
overdiagnosis and overtreatment of malaria without any negative consequences for febrile 
RDT-negative patients that do not receive antimalarial treatment [21, 45, 46]. RDTs are quick 
and simple to perform, easy to interpret and not as prone to human-error as many other 
diagnostic methods. Their main limitation is that reinfection or recrudescence of infection is 
difficult to identify, as RDTs detecting histidine-rich protein 2 (HRP2) can remain positive 
for more than 14 to 56 days after completed treatment [47-49]. Especially in areas with 
moderate to high endemicity this may pose a diagnostic challenge [50]. The sensitivity and 
specificity and reliability of results of malaria RDTs varies greatly between products and 
manufacturers [51]. RDTs generally have a lowest limit of detection of approximately 100 
p/l [42].  
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Antigens that can be detected by RDTs are HRP2, Plasmodium lactate dehydrogenase 
(pLDH), and aldolase. Various combinations may be identified through separate antibody 
bands on a single RDT. HRP2 is a P. falciparum-specific antigen, though P. falciparum 
parasites in certain areas do not express HRP2 [52], while tests detecting pLDH can either 
detect all species (PAN; P. falciparum, P. ovale, P. vivax, and P. malariae) or be species-
specific for P. vivax or P. falciparum [53]. The antigen pLDH is cleared approximately at the 
same time as the parasites are cleared from the blood and thus corresponds better with clinical 
infection than HRP2, which persists long after treatment. However, RDTs detecting pLDH 
are generally less sensitive than those detecting HRP2 [54] though studies vary in their 
conclusions [55]. RDTs detecting aldolase have proven to have very low sensitivity [56]. All 
three antigens are also expressed by gametocytes, which may persist post-treatment [53].  
 
1.2.4 Polymerase chain reaction (PCR)  
PCR has generally only been used for research purposes. It has been attempted implemented 
for routine malaria diagnostics of imported cases in a European hospital over a shorter period 
of time, but the attempt did not result in a permanent change of first-line routine malaria 
diagnostics [57]. The greatest advantage of PCR is its high sensitivity and specificity [44, 58, 
59]. It is, however, an time-consuming method requiring specialized expertise and expensive 
equipment to perform [60]. A PCR assay of one sample may cost up to approximately 6-9 
USD depending on the methods used for extraction of DNA and for PCR [61] compared to 
0.82-4.93 USD for a RDT depending on the manufacturer and type of RDT [62, 63]. 
Optimization of PCR assays and newer PCR techniques with simpler DNA extraction and 
analysis of PCR products may in the future make PCR feasible for routine malaria diagnostics 
in high resource settings [64]. 
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Traditionally, DNA template for use in PCR reactions for Plasmodium species has been 
extracted from whole blood. However, dried blood on filter paper (dried blood spot, DBS) has 
been used increasingly in recent years [65-71]. PCR is a robust technique and DNA from 
properly stored and transported material can be extracted many years after collection for PCR 
analysis [40]. 
 
1.2.4.1 Dried blood spots (DBS) 
While various methods have been employed for extracting DNA from DBS few studies have 
been done comparing different DNA extraction methods [72, 73]. Most of the studies that 
have been done on extraction methods include few methods tested on unstandardized samples 
[68, 74, 75]. Studies have shown some discrepancies in results between whole blood and DBS 
varying from very little or nothing to a 10- to 100-fold decrease in sensitivity when using 
DBS rather than whole blood [43, 76, 77]. The reliability of DBS is therefore somewhat 
uncertain. Nonetheless many studies use DBS as the sole source of DNA template for 
detecting malaria or for testing for resistance genes [67, 78, 79]. As a source of DNA, DBS 
have the potential to be used to investigate malaria prevalence as well as monitor antimalarial 
resistance genes and perform genotyping of parasites to monitor whether infections are new 
or recrudescent [24, 49, 80]. The practical advantages of DBS are the main reason they are an 
attractive method. Patients or study subjects generally perceive collecting blood drops by 
finger-prick as less invasive, less painful and a more agreeable procedure than obtaining 
blood samples by venipuncture [81]. Storage and transportation of DBS is much simpler than 
for whole blood samples and therefore is attractive for use in remote, rural areas in a resource-
poor setting where a cold chain may be lacking.  
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1.3 Diagnostics and treatment decisions 
A clinicians basis for selecting treatment is complex. A febrile child is a diagnostic challenge 
both because of the challenges with the diagnostic methods and overlapping clinical 
presentations of illnesses, as outlined above, and other factors such as a childs more limited 
ability to communicate their subjective experience of their illness. When laboratory facilities 
are lacking or unreliable, treatment decisions may often target a broad spectrum of etiologies 
in order to avoid undertreatment and increase survival. The result may be overtreatment with 
both antimalarials and antibiotics, which drives antimicrobial resistance, especially when 
suboptimal doses of medication are used or antimicrobial treatment courses are not completed 
[82-84]. Even when laboratory facilities are present, clinicians may not have faith in the 
diagnostics done and may treat patients for malaria or other infections despite negative 
laboratory results [21, 23, 85-87]. The widespread availability of antimalarials over-the-
counter in many malaria-endemic countries may also contribute to overuse of the drugs [88-
90].  
 
The recommended antimalarial treatment of uncomplicated P. falciparum infection is 
artemisinin combination therapy (ACT) [24]. Resistance has developed in P. falciparum 
parasites to other previous commonly used treatments such as sulfadoxine-pyrimethamine 
(SP) and chloroquine [91]. SP is still used in intermittent preventative therapy in pregnant 
women [92], but chloroquine has lost its place entirely in official P. falciparum treatment and 
prevention recommendations [24, 91]. Despite the solid documentation of resistance to these 
antimalarials they are still available in many pharmacies in sub-Saharan Africa [93]. A recent 
study by Selemani et al showed that only 58% of malaria cases received the recommended 
treatment with ACT [94]. Febrile illness may in some cases be a medical emergency with 




&
danger signs. In these cases presumptive treatment of various possible causes of illness may 
be necessary and correct practice.  
1.4 Malaria immunity 
Children in areas with high malaria transmission have a marked reduced risk of severe 
malarial disease after their second year of life and may develop some immunity to severe 
malarial infection already after one or two infections [95]. In areas with low to moderate 
transmission it may take up to the childs fifth birthday before a significant reduced risk of 
severe infection is observed [96]. It appears that if exposure to malaria is too low, with too 
few infectious mosquito bites per year, the immunity an individual has developed will wane 
[97]. Older children and adults in malaria-endemic areas are less susceptible to developing 
clinical malaria infection and are able to clear parasites more quickly while receiving 
antimalarial treatment as well as without antimalarials [98]. Full immunity to malaria has not 
yet been found and the mechanisms of malarial immunity are complex [99]. 
 
1.5 Asymptomatic malaria infection  
Asymptomatic malaria infection can pose a challenge in the diagnosis of febrile illness.  
It is generally accepted that inhabitants of malaria-endemic countries can have asymptomatic 
malaria parasitemia [100, 101]. Varying prevalence of asymptomatic malaria parasitemia has 
been identified in different populations studied with low levels such as 1.7-8.7% shown in 
one area in Gabon [100], while higher levels of 12%, 27%, and 52% were found by 
microscopy, RDT, and PCR respectively, among another adult Gabonese population studied 
[102]. In yet another study, in Gambia, it was concluded that true asymptomatic malaria 
parasitemia was uncommon in children [103]. In an area in Kenya 33.8-73.8% of a studied 
population had asymptomatic infection [101] and 33.1% in a study in Nigeria [104]. These 
variations in prevalence underscore the importance of further studies being performed in 
	




various populations to determine the significance of asymptomatic malaria in different areas. 
Individuals with asymptomatic malaria parasitemia presenting with febrile bacterial or viral 
infection may at the same time having a positive malaria test, which can cause clinicians to 
overlook the true cause of illness. However, there is also evidence that malaria may 
predispose for invasive bacterial disease [105]. 
 
Asymptomatic malaria is not only present in high transmission areas but has also been 
identified in low transmission settings [106]. A recent study demonstrated that the proportion 
of subpatent infections detectable by PCR was high in northwestern Tanzania indicating the 
value of using PCR rather than only RDT and microscopy in research on prevalence of 
malaria parasitemia in a population [71]. It is especially important to detect asymptomatic 
malaria infections in an elimination setting [107] as individuals with asymptomatic 
gametocytemia can act as a reservoir for perpetuating the malaria cycle by infecting 
mosquitoes. An estimated 14-40% of mosquito infections may come from individuals 
carrying submicroscopic quantities of malaria parasitemia in an area with a low blood slide 
malaria positive prevalence of about 3%, according to a study by Okell et al [108]. 
Asymptomatic individuals do not seek medical treatment and therefore can potentially infect 
mosquitoes over a long period of time. Artemisinin combination therapy has been shown to 
reduce gametocyte persistence more than some other antimalarials and is therefore a useful 
drug with malaria elimination in mind [109]. 
 
Gametocytemia appears to be higher among asymptomatic than symptomatic individuals 
[110], which may be because gametocytemia peaks about 7-10 days after the peak of asexual 
parasitemia with P. falciparum [8] and asymptomatic infections are most often longer in 
duration than symptomatic infections. Gametocytemia is dependent on age and mostly found 
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in children in areas with high malaria transmission. In areas with lower malaria transmission 
intensity the association with age is much less [111]. 
Patients with asymptomatic malaria parasitemia are less likely to develop an acute malaria 
attack [112]. Asymptomatic malaria parasitemia therefore appears to reflect a form of partial 
immunity to malaria.  
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2. RATIONALE OF THE STUDY  
Malaria is a disease that affects a large proportion of the worlds population. The diagnostics 
are challenging with many limitations both in clinical and laboratory diagnostics. Newer 
methods of diagnostics are emerging including increased use of RDTs clinically and PCR in 
research and mapping of malaria epidemiology. Comparisons of diagnostics have previously 
been done, but with varying malaria transmission intensity in different areas and variations in 
performance of the methods used, further studies are required. Asymptomatic malaria 
parasitemia can theoretically pose a problem in diagnosing malaria in febrile illness as other 
causes of fever might be overlooked if malaria parasitemia is present concomitantly with 
another infection. Asymptomatic malaria parasitemia has been identified in many areas and it 
is therefore relevant to investigate for it in the current setting in order to assist in the 
interpretation of malaria results from febrile children. Furthermore, asymptomatic malaria 
represents a reservoir for transmission of malaria, and thus has implications for efforts to 
eliminate malaria. With increasing use of DBS in malaria research and few studies done 
comparing more than just a few DNA extraction methods a larger comparison of methods for 
DNA extraction from DBS using a standardized sample is warranted. Also only few 
comparisons of whole blood and filter paper as sources for DNA for malaria investigation 
have been done despite DBS being used in many studies. 
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3. AIMS OF THE STUDY 
Primary aims: 
1. Evaluate and compare malaria diagnostics using routine and research microscopy, 
DBS and whole blood PCR, and RDTs in a resource-poor malaria-endemic setting.  
2. Assess the prevalence of asymptomatic malaria parasitemia in the study population. 
 
Secondary aims: 
1. To assess the quality of routine malaria diagnostic tests in the study area. (Paper I) 
2. To compare the performance of routine diagnostics with thick blood smear 
microscopy, thin blood smear research microscopy, RDT, and PCR on both whole 
blood and DBS. (Papers I, III and IV) 
3.  To assess the association between clinical signs and laboratory confirmed malaria 
cases, as defined by the various diagnostic methods. (Paper I) 
4. To determine the prevalence of asymptomatic malaria parasitemia in the population 
and its significance for malaria diagnostics if it is present. (Paper II) 
5. To assess the utility of DBS as an alternative to using whole blood as a source of DNA 
for PCR. (Paper III and IV) 
6. To identify a reliable and cost-effective method with a low limit of detection for 
extraction of DNA from DBS. (Paper III) 
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4. STUDY POPULATION AND METHODS 
4.1 Study area 
4.1.1 Dar es Salaam and Tanzania 
Tanzania had a population of 44,9 million people with 4,36 million people living in the Dar es 
Salaam region in 2012 [113]. Malaria is less prevalent in large cities and urban areas than in 
rural areas in sub-Saharan Africa. A recent study by Pond showed a 0.3% malaria prevalence 
in Dar es Salaam as compared to 3.9% in surrounding rural areas when using blood 
microscopy [114]. Approximately 73% of Tanzanians live in areas with high transmission of 
malaria and Tanzania had approximately 5,48 million suspected and confirmed malaria cases 
in 2011. P. falciparum is the dominating species of malaria in this area [2]. The cost of 
prevention and treatment of malaria in children under five years of age in Tanzania was 
0.62% of the countrys gross domestic product (GDP) in 2009 [115] and thus represents a 
considerable expense for the Tanzanian government which spends a total of 7.3% of the 
nations GDP on healthcare [116].   
 
4.1.2 Muhimbili National Hospital 
Muhimbili National Hospital (MNH) is a large tertiary referral hospital in Tanzania receiving 
admissions from all over the country as well as local admissions. MNH is located near the 
city center of Dar es Salaam. It is also a teaching hospital with close contact with Muhimbili 
University of Health and Allied Sciences (MUHAS), which is a large teaching institution with 
schools of medicine, dentistry, nursing, pharmacy and public health. Many complicated 
patient cases are referred to MNH for further management. There are a total of approximately 
1500 beds at MNH. The Pediatric and Child Health Department consists of wards for 
oncology, malnutrition, diarrhea, pediatric surgery, a burn unit, two general pediatric wards 
and an acute pediatric care unit. In total there are 217 beds in the department. 
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4.1.3 Magomeni maternal and child health clinic (MCHC) 
Magomeni MCHC is a clinic with facilities for basic diagnostic and health promoting work 
and is located centrally in Dar es Salaam not far from MNH. Children are brought to the 
clinic by their parent or guardian for vaccination, weighing and malaria testing or other basic 
diagnostic measures.  
 
4.2 Study populations 
An overview of the populations used in the various papers and how they are related to each 
other can be found in Figure 1.  
 
Children presenting with fever or a chief complaint of fever that were admitted to the general 
pediatric wards and acute pediatric care unit at MNH in Dar es Salaam, Tanzania from 
January to June 2009 were recruited for the study after informed consent (Papers I and IV). 
When comparing the patients that had consented that were included and excluded from the 
analysis (Table 1), the only variables significantly (p<0.05) different were mosquito net use, 
AB use within the previous four weeks and length of hospital stay.  
 
At Magomeni MCHC, 108 children that had not had fever or been treated with antimalarials 
the past four weeks according to their parent or guardian and were coming for a check-up at 
the health clinic were recruited after informed oral and written consent (Paper II).  
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Table 1: Comparison of population characteristics of included and excluded patients (Paper I) 
 
Characteristic or finding  
(N=included/excluded) 
Included  
% or value (range) 
Excluded  
% or value (range) 
Demographics   
   Age in months, median (N=300/161) 13.0 (1.0-100.0) 12.0 (1.0-99.5) 
   Gender – female (N=304/164) 42.8 46.3 
   Weight in kg, mean (N=272/145) 8.7 (1.5-21.0) 9.0 (1.6-22.0) 
History   
   Referral from other hospital (N=276/97) 67.8 71.1 
   Mosquito net used (N=262/137) 96.2 85.4* 
   Convulsions (N=284/157) 23.6 23.6 
   Duration of illness in days, mean (N=291/154) 10.4 (1-270) 9.4 (1-180) 
   Antimalarial previous 4 weeks (N=270/150) 62.6 61.3 
   Antibiotics previous 4 weeks (N=274/149) 74.8 65.8* 
   Travel previous 4 weeks (N=257/135) 25.7 20.7 
Clinical findings   
   Tachypnea (N=284/145) 54.9 54.5 
   Jaundice (N=297/102) 12.1 7.8 
   Reduced consciousness (N=299/154) 25.1 29.2 
Laboratory test results   
   Hemoglobin in g/dl, mean (N=302/157) 8.1 (2.2-13.9) 8.4 (1.7-13.4) 
   Platelet count in K/l, mean (N=299/152) 335.4 (2.4-1114.0) 330.4 (8.0-1185.0) 
   
Length of hospital stay in days, mean (N=304/162) 7.0 (1.0-71.0) 8.4 (1.0-210.0)* 
Outcome – dead (N=304/163) 22.4 21.5 
*statistically significant difference between included and excluded cases (p<0.05). 
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4.3 Study design 
The studies for Papers I and II were done as clinically- and laboratory-based prospective, 
observational studies. The study of DNA extraction methods from DBS (Paper III) and the 
comparison of PCR on DNA extracted from DBS and whole blood (Paper IV) were 
methodological studies.  
 
4.4 Material and methods 
4.4.1 Social data, laboratory results and collection of materials 
Sociodemographic, clinical and laboratory details and results were registered on two different 
case report forms (CRFs) for the study of febrile children and that of asymptomatic children, 
respectively (see appendix). The information for the CRF was collected by questioning the 
parent/guardian and/or consulting the childs medical file. Date of birth, gender, mothers 
level of education, and whether the child was referred from another hospital, slept under a 
mosquito net at home, had permanent residence in Dar es Salaam, had known sickle cell 
disease, had convulsions before admission and how long the child had been ill were recorded. 
Whether treatment with antimalarials and antibiotics had been given and whether the child 
had travelled outside Dar es Salaam during the previous four weeks before admission were 
also documented. Upon admission, weight, axillar temperature, respiratory rate and 
heart/pulse rate (tachypnea and tachycardia both defined according to pediatric WHO 
guidelines [117]), spleno- and hepatomegaly, abdominal distension, jaundice, palmar pallor, 
and level of consciousness were recorded. Hematological data including hemoglobin level, 
platelet count, erythrocyte count, and leucocyte total and differential counts were recorded 
along with routine blood slide result, and results of blood culture if done. In-hospital 
treatment with antimalarials and/or antibiotics, length of hospital admission, as well as 
outcome dichotomized as dead and alive was documented.   
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Thick blood smears were stained with Fields stain and examined as part of the hospital 
routine at MNH. Parasitemia was reported as number of parasites seen per 200 white blood 
cells. Results of blood slide microscopy for malaria, hematological data as well as clinical 
observations were recorded. 
 
4.4.2 Research blood smear microscopy 
Thin blood smears were prepared at the ward and dried and stored before transport. 
Retrospectively, the blood smears were fixed with methanol and then stained with 5% Giemsa 
stain and 100 fields were examined with oil-immersion on high magnification before a slide 
was deemed negative. Parasitemia on positive slides was reported as percent of erythrocytes 
infected.  
 
4.4.3 DNA extraction – whole blood 
A vial containing EDTA-blood remaining after routine hematological testing was kept frozen 
at -20°C for 2 to 2.5 years until DNA extraction was performed. DNA was extracted from 
whole blood using a QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) according 
to the manufacturers instructions (Paper I). This method was selected, as it is the routine at 
the laboratory where the work was carried out and is a reliable method that has performed 
well in previous studies [44, 118-120].  
 
4.4.4 DNA extraction - DBS 
From the febrile children, DBS were collected by dropping two drops of blood from a syringe 
on a segment of Whatman Schleicher & Schuell filter paper, grade 589/2 (Whatman GmbH, 
Dassel, Germany) while collecting routine blood samples (Paper IV). In the asymptomatic 
malaria parasitemia study, blood collected by finger prick was blotted on a segment of filter 
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paper. Thereafter the DBS were stored in airtight pockets after completely air-drying. Initially 
the DBS were stored at room temperature protected from sunlight for three to nine months. 
Later they were stored at -20°C for approximately 3.5 years until DNA extraction was 
performed.  
 
The cleaning method of the puncher (Harris Uni-Core™ puncher, Qiagen, Hilden, Germany) 
between punching circles from DBS was developed based on the manufacturers and 
distributors recommendations and tested to ensure no transfer of parasites between samples 
(Paper II). Both sodium hypochlorite (NaClO) and 100% ethanol were used in the cleaning 
process along with punching of blank filter paper. Care was taken to avoid transferring liquid 
to the DBS during the cleaning process. 
 
Several methods of extraction from DBS were tested and compared using DBS prepared from 
a 2- and 5- fold dilution series of an external reference sample of Plasmodium falciparum, US 
04 F Nigeria XII (WHO Specimen Bank at Centers for Disease Control and Prevention in 
Atlanta, GA USA) in malaria negative blood. For each DBS, 50  blood was placed on a 
segment of the same type of filter paper as for the clinical samples described above. These 
DBS were air-dried a minimum of overnight before using them for DNA extraction. Seven 
different methods for DNA extraction from DBS were tested including three different 
methods using Chelex-100 Molecular Biology Grade Resin (Bio-Rad Laboratories, 
Hercules, CA, USA) [72, 78, 121-129], two using InstaGeneTM Matrix (Bio-Rad Laboratories, 
Hercules, CA, USA) [74, 127], QIAamp® DNA Mini Kit (Qiagen, Hilden, Germany) [68-70, 
102, 122] and a method using TE-buffer [72]. The best and most consistent method (detecting 
the most consecutive dilutions) was used on the clinical DBS that had been stored for 
approximately four years (Paper IV). 
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4.4.5 PCR 
A genus-specific PCR was done on DNA extracted from whole blood and from DBS using a 
novel PCR assay targeting Plasmodium mitochondrial genome [44]. The same PCR-method 
was also used for the comparison of methods for DNA extraction from DBS. Species-specific 
PCR was done on samples positive by whole blood PCR using a method targeting the 
ribosomal 18S gene [130]. Samples negative by species-specific PCR were sequenced [44]. 
These PCR methods were chosen, as they are established methods used at the laboratory 
where the samples were analyzed and had also previously performed well demonstrating high 
sensitivity and specificity when compared to a reference nested PCR method [44].  
 
4.4.6 RDT 
RDTs were performed as instructed by the manufacturer (Papers I and II). Different types of 
RDTs were used for the two studies. The RDT used in the study of febrile children detected 
both HRP2 antigen and PAN pLDH antigen despite that only P. falciparum was expected. 
This was useful to assist in classifying cases as current or recent malaria infection and to 
increase likelihood of detecting all malaria infections. For the study of asymptomatic children 
an RDT only detecting HRP2 was used. An RDT detecting only HRP2 was considered 
sufficient because only P. falciparum infection was suspected in the population and detecting 
HRP2 is more sensitive than pLDH and therefore increases the likelihood of detecting 
asymptomatic cases with low parasitemia. For the asymptomatic study, blood was collected 
from a prick in the childs finger to perform the RDT. For the febrile children the RDT was 
performed retrospectively on EDTA-blood that had been kept frozen at -20°C for four years. 
Both of the RDTs that were used were recommended according to the Global Fund Quality 
Assurance Policy [131]. The RDT used in Paper II was selected based mainly on accessibility 
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while the RDT selected for Paper I was based on its performance during WHO RDT testing 
[51], price and availability.  
 
4.5 Statistical analysis 
Statistical analysis was done using IBM SPSS Statistics version 19 (SPSS Inc, IBM company) 
and statistical significance was defined as p-value <0.05. For categorical variables statistical 
analysis was performed using Chi-squared test, or Fishers exact test for analyses of variables 
with few observations. Multivariate analysis was done using automated and manual 
backward-stepwise logistic regression on all variables with p-value <0.2 in the univariate 
analysis. Variables with less than 250 patients with both RDT result and data for the variable 
being analyzed available, that also were considered less relevant factors based on previous 
studies and on the univariate analysis, were excluded from the multivariate analysis for 
predictors of positive RDT (Paper I). Other basic statistics, such as frequency counts, were 
also performed using SPSS.  
 
4.6 Ethical considerations 
A research permit was obtained from the Tanzania Commission for Science and Technology 
(COSTECH), and ethical clearance was received from the appropriate bodies at MUHAS and 
MNH and from the Regional Ethical Committee of Western Norway. The study was done in 
collaboration between MUHAS/MNH and the University of Bergen/Haukeland University 
Hospital, Norway. The parent or guardian of each child received oral as well as written 
information, if desired, in English or Swahili. Written consent was obtained from the parent 
or guardian of each child by signature or fingerprint.  
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Thin blood smears, frozen EDTA-blood (kept frozen using dry ice) and DBS were 
transferred, using the MUHAS material transfer agreement, to the University of Bergen in 
Norway for analysis.  
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5. SUMMARY OF RESULTS OF PAPERS 
5.1 Paper I 
 
 
Challenges in diagnosing paediatric malaria in Dar es Salaam, Tanzania. 
Strom GE, Haanshuus CG, Fataki M, Langeland N, Blomberg B  
Malar J 2013, 12:228. 
Objectives: To study clinical and laboratorial diagnostics of malaria in febrile children 
admitted to the general pediatric wards at Muhimbili National Hospital in Dar es Salaam, 
Tanzania and also to determine the morbidity and mortality attributable to malaria in the study 
population. The study aimed to compare various diagnostic methods for malaria. 
Results: Among the 304 children included in the study, 62.6% had received antimalarials 
during the previous four weeks prior to admission, and 65.1% and 96.1% received 
antimalarials and antibiotics, respectively, during admission. Routine thick blood smears, 
research blood smears, PCR, and RDTs detected malaria in 13.2%, 6.6%, 25.0% and 13.5% 
of patients, respectively. Positive routine microscopy was confirmed in only 43%, 45% and 
53%, by research microscopy, RDTs and PCR, respectively. Eighteen percent had positive 
PCR but negative research microscopy. Reported low parasitemia on routine microscopy was 
associated with negative research blood slide and PCR. RDT-positive cases were associated 
with signs of severe malaria. Palmar pallor, low hemoglobin and low platelet count were 
significantly associated with positive PCR, research microscopy and RDT.  
Conclusions: The true morbidity and mortality attributable to malaria in the population 
remains unknown due to the wide discrepancies in results between the diagnostic methods. 
The current routine microscopy seems to result in overdiagnosis of malaria and, consequently, 
overuse of antimalarials. RDTs appear to have the potential to improve routine diagnostics. 
The clinical implication of the many RDT-negative and PCR-positive patients needs to be 
elucidated. 
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5.2 Paper II 
 
No asymptomatic malaria parasitaemia found among 108 young children at one health 
facility in Dar es Salaam, Tanzania. 
Strom GE, Tellevik M, Fataki M, Langeland N, Blomberg B  
Malar J 2013, 12:417 
Objectives: To investigate whether asymptomatic malaria parasitemia was present in a 
population parallel to a febrile pediatric population studied at the Muhimbili National 
Hospital general pediatric wards. Also, to determine the asymptomatic malaria parasitemia 
prevalence among children in the area in order to improve interpretation of the results of the 
study of malaria in febrile children.  
Results: Of the 108 asymptomatic children included, none had malaria parasitemia detectable 
by RDT or PCR of DBS. The median age of the children was 4.6 months ranging from 0.5 to 
38 months. Nearly all the children were reported to be sleeping under a bed net. 
Conclusion: There appears to be no asymptomatic malaria parasitemia in the studied 
population. However the low median age and the small sample size for the study taken only 
from one health facility make the results inconclusive and they cannot be generalized to a 
larger population. Further studies that are larger, with higher age groups and including various 
locations both rural and urban should be performed. 
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5.3 Paper III 
 
Comparison of four methods for extracting DNA from dried blood on filter paper for 
PCR targeting the mitochondrial Plasmodium genome 
Strom GE, Tellevik MG, Hanevik K, Langeland N, Blomberg B 
Manuscript submitted  
Objective: Identify the most sensitive and consistent of commonly used methods for 
extracting DNA from DBS.  
Results: The Chelex-100, InstaGene matrix, and QIAamp kit methods performed 
similarly resulting in malaria detection in all dilutions to a limit of 0.5 to 2 p/l while the TE-
buffer method performed poorly. The Chelex-100 method using soaking of DBS punches 
overnight in saponin in phosphate-buffered saline (PBS) proved to be the method resulting in 
the lowest parasite detection level and most uniform results and was also a cheap method. To 
compare the two methods with the lowest limit of detection on true clinical samples 31 DBS 
that were collected from febrile patients four years earlier and were positive for malaria as 
determined by mitochondrial PCR done on whole blood were tested with both methods. The 
same clinical DBS (13) were found positive when DNA was extracted from DBS using both 
the Chelex-100 and InstaGene matrix methods with the lowest limits of detection.  
Conclusion: Simple and low-cost methods for extracting DNA from DBS can be useful and 
perform well. They can potentially detect low-grade parasitemia and when combined with a 
sensitive PCR-method they may prove to be a good alternative to PCR done on DNA 
extracted from frozen whole blood. Evaluation of the methods with the lowest limit of 
detection on clinical samples indicates that extracting DNA from clinical DBS may have 
much lower sensitivity than extracting DNA from whole blood. 
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5.4 Paper IV 
 
PCR targeting Plasmodium mitochondrial genome of DNA extracted from dried blood 
on filter paper compared to whole blood. 
Strom GE, Moyo S, Fataki M, Langeland N, Blomberg B.  
Manuscript submitted 
Objectives: To compare the results of genus-specific Plasmodium PCR on DNA extracted 
from EDTA-blood and from DBS collected from febrile pediatric admissions four years 
earlier. The study also aimed to compare PCR of DNA from DBS to thin research blood 
smear microscopy and RDT results.  
Results: Of whole blood samples, 24.5% were positive on mitochondrial Plasmodium genus-
specific PCR and 11.2% of DBS were positive by the same PCR method. All patients with 
positive DBS samples were also positive by P. falciparum species-specific PCR done on 
DNA extracted from EDTA-blood. All RDT-positive patients were also positive on PCR of 
DBS. One patient was positive on PCR of DBS but negative on RDT. Three research 
microscopy positive cases were negative on PCR of DBS and one of them was also negative 
on whole blood PCR.  
Conclusion: PCR of DNA extracted from whole blood appears to perform superior to PCR of 
DBS. DBS PCR detected more cases than were detected by RDT and microscopy, though not 
all cases positive by microscopy were positive by DBS PCR. Because of the many practical 
advantages of DBS, when it comes to storage and transport, the method will likely remain an 
alternative that is relevant for research purposes despite the low sensitivity found in this 
study. Further studies are needed in this area.  
 
 
 
	



 %
6. DISCUSSION 
6.1 Discussion of main findings 
6.1.1 Routine malaria microscopy 
The large misdiagnosis of malaria by routine microscopy of thick blood smears identified in 
this study (Paper I) has also previously been described in several studies [35, 87, 132]. Only 
43-53% of positive routine blood smears for malaria were confirmed positive retrospectively 
by research diagnostic methods (research thin blood smear microscopy, RDT, or PCR of 
whole blood), indicating overdiagnosis by routine microscopy. In addition, 55 PCR positive 
samples were not positive on routine microscopy (Paper I), which indicates underdiagnosis by 
routine microscopy. Poor quality microscopes and staining solutions along with high 
workload and insufficient training of personnel have previously been identified as 
contributing factors to the misdiagnosis of malaria by microscopy and these factors may also 
have contributed in this setting [34, 133]. Despite the fact that the routine diagnostics 
performed so poorly, a significant association was found between high parasitemia (>10,000 
parasites/l) on routine blood smear and positivity by PCR. This indicates that the cases with 
high parasitemia, which should not be missed due to their increased likelihood of clinically 
severe illness [134], indeed were not overlooked by routine microscopy. The many 
overdiagnosed cases are likely due to microscopists mistaking artifacts or blood components 
for Plasmodium parasites [32], as these were reported as having low parasitemia.  The study 
indicates that “scanty malaria” reported from routine thick blood smear microscopy has a high 
likelihood of being false positive. There was no significant difference in case fatality rates 
between cases positive only by PCR and negative by all other diagnostic methods as 
compared to those positive by other methods. This is likely due to malaria overtreatment in 
hospital, with approximately two-thirds of all patients receiving antimalarials during 
admission. In addition, this may indicate that the parasitemia only detected by PCR may be 
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clinically insignificant remains of parasites post-treatment or asymptomatic parasitemia with 
concomitant alternative illness. With only 13% of patients being positive by routine blood 
smear microscopy the high level of treatment with antimalarials indicates that clinicians lack 
confidence in routine malaria diagnostics. Given the poor accuracy of the diagnostic tests, it is 
understandable that clinicians do not follow test results, but this also leads to vast 
overtreatment of malaria. A significantly higher number of PCR positive, routine microscopy 
negative patients received antimalarial treatment than PCR negative, routine microscopy 
negative cases (p<0.001) despite the fact that the PCR was performed retrospectively and was 
not available to the treating physician. The results of this study support the findings of 
previous studies that routine diagnostics with microscopy are poor in many health institutions 
and should be improved or alternative methods employed [30, 34-36].  
 
6.1.2 Comparing the study diagnostic methods 
Recent studies have identified varying sensitivities of different diagnostic methods for 
malaria. The same inconsistency between microscopy, RDT and PCR results as was found in 
Paper I, with PCR detecting malaria in more cases than the other methods, has also previously 
been described [111, 135-137]. The sensitivity and specificity of microscopy with PCR as the 
gold standard found in a study by Manjurano et al [138] was similar to that reported in Paper 
I. A limitation of this study is that no true gold standard with definite clinical applicability 
was identified. 
 
Blood microscopy has long been the gold standard for malaria diagnosis but the results of the 
current study support the notion, also previously implied [43, 44, 139], that molecular 
diagnostics have the potential to become the new gold standard and most reliable method for 
malaria diagnostics. The feasibility of PCR in a clinical setting and especially in low-income 
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countries is however limited by the methods relatively high cost, labor-intensiveness and that 
it is time-consuming. Specialized equipment and trained personnel are also required, limiting 
the applicability of the method. PCR is a molecular technique with several variants including 
conventional, nested and real-time PCR. Within these given PCR variants the variation in 
sensitivity and specificity is not only dependent on the PCR method used but also on the 
primer and target sequence used and the protocol. There are also advantages and 
disadvantages with each method in how time-consuming and labor-intensive the methods are, 
risk of contamination, and whether they can provide quantification of parasitemia [140]. 
Results of studies using different protocols for PCR could potentially vary greatly and to a 
certain degree be difficult to compare. However, studies done so far comparing PCR methods 
have shown surprisingly consistent results between methods [141]. Nested PCR is often 
considered a gold standard among molecular techniques [141]. The PCR method used in the 
current study was a conventional single round method with a mitochondrial target gene that is 
present in more copies than many other genes in the Plasmodium parasite [44]. This makes 
the method more sensitive than would be expected for most other single round conventional 
PCR protocols targeting other genes. It also proved slightly superior when compared to a 
commonly used gold-standard/reference nested PCR method [44]. This supports the high 
sensitivity of the mitochondrial PCR when used for malaria detection as was found in Paper I 
and also assumed when interpreting the results of Papers II-IV. 
 
During microscopy of 100 high-powered fields of a thin blood smear only about 0.006 l 
blood is examined and in just as many fields of a thick blood smear, 0.16-0.23 l blood is 
examined, which is over 25 times more than by thin blood smear [142]. In the PCR assay 
used, 2 l DNA template was used, which is equivalent to 4 l whole blood. With a lowest 
parasite detection level of 0.5 p/l, theoretically it would be expected that the PCR would 
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detect as little as two parasites in the added DNA template. When using six 3 mm punches 
from DBS as the source for DNA template, 2 l DNA template is equivalent to approximately 
0.7 l blood on the filter paper. The whole blood technique therefore analyzes almost six 
times as much blood as when DBS are used. The PCR methods, whether using whole blood 
or DBS, analyze more blood than is examined on blood smears. This may account for the 
higher sensitivity of PCR as compared to microscopy and RDTs. For the RDTs used in the 
current studies (Papers I and II) approximately 5 l blood was used, but RDTs detect antigens 
rather than parasites and the quantities of blood examined can therefore not be readily 
compared.  
 
6.1.3 DBS as an alternative to whole blood for PCR  
Drying blood on filter paper has become a highly used method in malaria research, however 
the results presented in Papers III and IV draw the reliability of this method into question. The 
PCR using DBS as a source of DNA detected a similar number of cases as the RDTs and 
detected more malaria cases than research microscopy, though three research microscopy 
positive cases were negative on PCR of DNA from DBS (Paper IV). As collection and 
transport of whole blood is more difficult, DBS are likely the best source of DNA template 
for PCR in certain situations despite a lower sensitivity than for whole blood. RDTs have the 
limitation that not all species can accurately be identified on the spot, however methods have 
been developed to extract DNA from RDTs for performing PCR and have proven to have 
similar limits of detection as PCR of DNA extracted from DBS [143]. Further testing can be 
done on the DNA extracted from the RDT for species-identification in addition to for 
example genotyping [24], testing for antimalarial resistance [66] or for quantification using 
real-time PCR. RDTs have also previously been shown to have low sensitivity, often having a 
limit of detection higher than 200 p/l [51]. 
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The method employing Chelex-100® and soaking in saponin overnight has also previously 
been proven superior to other methods for DNA extraction from DBS when only a few 
methods were compared [122] and is frequently used [78, 121, 124-126]. 
 
Species identification for the samples was done by using species-specific PCR targeting the 
18S gene or sequencing if the species-specific PCR was negative despite positive genus-
specific PCR. The species-specific PCR has been shown to be less sensitive than the 
mitochondrial genus-specific PCR as it detects fewer cases of malaria [44]. We therefore 
expect that cases negative on species-specific but positive on genus-specific PCR likely have 
lower parasitemia than those positive by both PCR methods. As all those positive by DBS 
were also positive on P. falciparum species-specific PCR done on whole blood from the same 
patients, this may suggest that cases with higher parasitemia were consistently detected by 
DBS (Paper III).  
 
The discrepancy between the DBS and whole blood PCR may have many causes. Previous 
studies have shown similar results whether whole blood or DBS have been used as sources for 
DNA template for PCR though few studies on this have been done [43, 76, 144]. One 
explanation for the discrepancy found may be that the amount of blood used in the template 
extracted from DBS is almost six times less than in the same amount of template extracted 
from whole blood (as explained in the section above). Thus fewer parasites are likely to be 
included in each assay when using DBS as the source of DNA as opposed to whole blood. 
When considering the results of the testing of DNA extraction methods from DBS it must be 
taken into account that the preparation of DBS from the dilution series was done in a much 
cleaner and well-organized environment than the clinical DBS were prepared in. The DBS 
that were made from the dilutions of the standardized reference blood sample were also used 
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shortly after preparation (after a minimum of air-drying overnight) for the comparison of 
DNA extraction methods as opposed to the clinical samples, which were stored for several 
years before examination. Thus there may be limitations in the applicability of the results of 
the methodological testing to examination of clinical DBS collected in a research setting with 
limited facilities. The DBS collected from febrile children for this study were however 
collected in a very realistic environment for field studies. One study has shown a superiority 
of DBS that had been stored over 4 years as compared to those stored for a shorter period of 
time, likely because some PCR inhibiting factors had degraded during storage [127]. It would 
be expected that when one method for DNA extraction from DBS proved superior to the 
others, the superiority might remain also after applying the methods to older DBS that all had 
been stored approximately for the same length of time. In order to further increase the 
applicability of the results of the study comparing methods for DNA extraction from DBS, the 
two DNA extraction methods that had the lowest limits of parasite detection were compared 
on clinical DBS from patients with positive whole blood PCR for malaria before concluding 
which method truly was superior. This was done to reduce the possibility that a method that 
proved superior on the standardized samples did not remain superior on the clinical DBS that 
had been stored for a long period of time and possibly under unfavorable conditions. The two 
methods that were compared gave the same results. The possibility remains that the limit of 
parasite detection may not be as low on the stored clinical DBS as for the newly prepared 
DBS of the dilution series, as the methods for extracting DNA from DBS were not compared 
on clinical samples with known quantities of parasites and stored for varying lengths of time. 
The DNA quality may also have been affected by the fact that the DBS had been stored under 
warmer conditions generally over 25°C for some months initially before they were 
transported and subsequently frozen at -20°C.  
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The choice of filter paper may also have influenced the results. The filter paper used in this 
study has not been verified in other studies and is not specifically produced for this purpose. 
The results of Paper III with a very low limit of detection of PCR of DNA extracted from 
DBS prepared on this filter paper supports that the filter paper is suitable for collection of 
DBS. However, it cannot be determined with certainty whether the filter paper used has a 
sufficient ability to preserve the DNA in the DBS over time.  
 
The fact that the Chelex-100®/saponin method for extracting DNA from DBS that was 
relatively inexpensive proved to be superior to the alternative methods (Paper III) supports the 
sustainability of using DBS for malaria research in low-income countries. Elute cards that 
were not tested in the comparison done here may prove superior, but due to the higher cost 
they were not considered relevant for this study. 
 
6.1.4 Implications of findings about diagnostics 
RDTs are being used increasingly in routine malaria diagnostics [42]. The findings in Paper I 
support that the use of RDTs may be a good alternative to microscopy when routine blood 
microscopy is suboptimal. Though RDTs are not as sensitive as PCR of DNA extracted from 
whole blood (Paper I), they showed similar detection of malaria cases as PCR of DNA 
extracted from DBS (Paper IV) and detected more malaria cases than by research microscopy. 
They also appear to detect the most clinically relevant cases, as positive RDT was associated 
with clinical signs of severe malaria (Paper I). The limitations of RDTs concerning follow-up 
of patients and following parasitemia levels during treatment, detecting recrudescence, and 
discerning certain Plasmodium species hinder RDTs in entirely replacing other forms of 
diagnostics [47-49, 53]. 
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The high number of samples positive on whole blood PCR and negative by all other methods 
are difficult to explain. PCR has been shown to detect as little as 0.002 p/l [145], but most 
other reports have higher limits of detection such as 0.5 p/l [44] or 1 p/l [40, 146]. High 
proportions of submicroscopic quantities of malaria parasitemia identified by PCR have also 
previously been shown [59, 137]. The high level of submicroscopic malaria reported in Paper 
I is similar to that found in a study done by Golassa et al in Ethiopia [137]. Both studies also 
identified positivity by microscopy that was half of that found by RDT. These submicroscopic 
cases may be asymptomatic malaria cases, may represent irrelevant malaria DNA persisting 
post-treatment in patients presenting with symptoms attributable to another co-infection [147, 
148], or the detected malaria parasitemia may be clinically relevant and the cause of the 
patients symptoms requiring treatment. The study done on healthy children showed no 
presence of asymptomatic malaria parasitemia in the population (Paper II). A recent study 
showed that most malaria infections under effective treatment were PCR negative after 
approximately 3 days [49], however this study was done using a PCR-assay targeting the 18S 
gene. Though this may indicate that cases only positive on PCR most likely are not post-
treatment cases, the PCR used in this study detecting mitochondrial Plasmodium DNA is 
likely to remain positive for a longer period of time than a PCR assay targeting the 18S gene 
as gametocytes, which often may persist post-treatment [149, 150], have a higher number of 
copies of the mitochondrial target gene than of the 18S gene [44]. They may be cases that 
were pre-treated with suboptimal concentrations of recommended antimalarial drugs or with 
non-recommended antimalarials causing reduced levels of parasitemia without full parasite 
clearance. In Paper I it is reported that 63% of the children had been pre-treated with 
antimalarials before admission and 16% of these had received other antimalarials than what 
was recommended by WHO. There was no increased case fatality rate among PCR-positive, 
routine microscopy negative cases that did not receive antimalarials as compared to those that 
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received antimalarial treatment. More information concerning how long the antimalarials had 
been used prior to admission, when the treatment had been given and at which doses would 
have assisted in interpreting these findings. However, in many cases this information most 
likely would not have been available due to poor memory recall or lack of documentation. A 
report by Hodel et al done in Tanzania indicated that antimalarials were present in the 
bloodstream of many more patients than those that reported recent antimalarial use [90]. 
Measuring the concentration of the most commonly used antimalarials in the blood of the 
children included upon admission would have given additional useful information. Similarly 
poor memory recall and a desire to please the investigator may have influenced other data 
collected from the parent or guardian of the participating child.  
 
No significant association was found between positive result on any of the study diagnostic 
methods (PCR of whole blood, RDT and research microscopy) and case fatality rate (Paper I). 
This suggests that there are other serious illnesses in addition to malaria in the population 
accounting for a large proportion of the deaths among study participants. The high total case 
fatality rate of 22.7% found among febrile patients included in this study was similar to that 
found in a study on systemic pediatric illness by Blomberg et al in 2001-2002, conducted at 
the same hospital, where a total of 17% of the included patients died and 20.2% of patients 
with malaria parasitemia died [151]. The high case fatality rate also for children with non-
malarial illness despite 96% of patients receiving antibiotics during admission suggests that 
the many children (two-thirds of study participants) referred from other hospitals may have 
sought treatment or been referred too late to the tertiary hospital where the study was 
conducted, treated with inappropriate antibiotics or suffered from other illnesses that were not 
treated appropriately. The lacking information of other causes of fever than malaria in the 
study participants is a weakness of this study that was not addressed, as diagnostic methods 
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for other causes of fever were not consistently available. Information concerning 
comorbidities could also have been an asset in this study. 
 
6.1.5 Clinical signs of malaria as defined by the various study methods 
Thrombocytopenia and anemia were associated with malaria as defined by PCR, RDT and 
research microscopy. Severity of palmar pallor was correlated to the degree of anemia. 
Assessing palmar pallor is therefore a useful clinical tool in a resource-poor setting where 
laboratory facilities may be lacking and hemoglobin levels cannot be measured. This 
association has also previously been shown for mild anemia when assessed by experienced 
and trained clinicians [152] and was confirmed by the findings in Paper I. The results reported 
in Paper I concerning the value of assessing palmar pallor to determine the degree of anemia 
in children were more promising than previously reported in other studies [153, 154]. It has 
previously been observed that palmar pallor is superior to conjunctival pallor in assessing 
anemia in African patients [152]. 
 
Various clinical signs were associated with malaria but none of these were specific or 
sensitive for identifying malaria cases. The findings support that malaria does not present 
with a clear clinical syndrome that can be diagnosed without laboratory or other testing. Not 
all clinical or laboratorial parameters were recorded for all patients (Table 1). There may be 
some concerns about the validity of the clinical data that was collected as the data was 
collected by various health professionals without any standardization beyond that is was done 
according to the established hospital routine.  
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6.1.6 Implications of not finding asymptomatic malaria in the population 
Asymptomatic malaria studies that have been done are difficult to compare. Some studies use 
DBS to identify parasitemia [102, 155, 156], another used whole blood PCR [136], some use 
RDTs [136, 155], while many studies only use blood smear microscopy [100, 101, 103]. As 
has been shown in Papers I, III and IV, the sensitivities of these methods vary greatly. 
Asymptomatic malaria cases often have low parasitemia though this varies from less than 100 
p/l to over 1000 p/l depending on the level of transmission in the area and the persons age 
[157, 158]. Sensitive molecular methods with low limits of detection such as PCR, rather than 
RDT and microscopy, are therefore likely best to identify these infections as also confirmed 
by a study by Ganguly et al [136]. The finding of no asymptomatic parasitemia in this study 
(Paper II) is difficult to interpret. It can be considered a confirmation of the strategy presented 
by WHO to test all patients with suspected malaria and only treat those with a positive test for 
malaria [24], but it also contradicts the finding in other studies done on asymptomatic malaria 
which have generally identified asymptomatic cases [100, 101, 103, 159]. A study by 
Coleman et al showed that the RDT they tested was inadequate for identifying low level 
parasitemia and thus asymptomatic parasitemia [160]. PCR of whole blood would likely have 
been more sensitive and could possibly have detected asymptomatic cases not found in this 
study due to the use of less sensitive methods (Paper IV). In addition the small sample size 
from only one health facility in an urban area with lower malaria transmission than 
surrounding rural areas may explain the findings. 
 
The use of insecticide treated nets (ITNs) along with increased use of artemisinin combination 
therapy (ACT) has likely contributed to reducing the burden of malaria in various countries 
including Zanzibar and northeastern Tanzania [161, 162]. The fact that most of the children 
included in the asymptomatic malaria study (Paper II) were reported as sleeping under a bed 
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net at home may contribute to the fact that no asymptomatic malaria was found among the 
children. However, the question about bed nets in the survey did not specify whether the nets 
were in good condition, were treated with insecticide or used every night. In addition, some 
parents/guardians may have over-reported bed-net use in order to please the investigator as 
coverage according to this studys findings is much higher (97%) than that found in the Dar es 
Salaam area in a study in 2008 (68%) [163].  
 
The participants in the study of asymptomatic individuals had a very low median age (4.6 
months) and were therefore less likely to have acquired asymptomatic malaria than those in 
the study of febrile children, which had a higher median age of 13.0 months (Paper I) [96, 
164]. Younger children are less likely to have submicroscopic quantities of malaria 
parasitemia as lower parasitemia during malaria infection is linked to increased age [108]. 
This may contribute to explaining why the level of submicroscopic malaria was so high in the 
study on febrile patients (Paper I) as opposed to the study on asymptomatic children (Paper 
II). A weakness of the study design for the asymptomatic malaria study was that the children 
were only examined at a certain point in time and if any parasitemia had been identified it 
would not have been possible, without follow-up of the children, to identify whether the 
children were in a pre-symptomatic phase of infection or truly had an asymptomatic infection 
[103, 165].  
 
Despite the limitations of both methods used when investigating for asymptomatic malaria, 
the results of the study may be applied to a population demographically similar to the patient 
study population to conclude that a positive DBS or RDT result using the same methods as 
described here most likely is a true clinically relevant malaria.   
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6.2 General limitations of the study 
The study population was small due to time limitations and initial communicational 
challenges in recruiting patients. In addition, as a consequence of missing information, 
results, and samples, the sample size was further limited. The study on asymptomatic malaria 
was meant as a small study to assess the situation and evaluate the methods. In order to obtain 
more useful and representative results the study population should have been expanded and 
included a broader age range and participants from both rural and urban areas. 
 
The study setting was an urban area with lower malaria transmission than surrounding rural 
areas. This limits the relevance of the study of asymptomatic malaria, as asymptomatic 
malaria parasitemia is less prevalent in areas of low than of high transmission. It also limits 
the general applicability of the results of the study of febrile children to urban populations 
similar to the one studied. The fact that the sample collection was done among admissions to 
a tertiary hospital is also a limiting factor as many uncomplicated as well as severe cases of 
malaria were likely to have been treated as outpatients or at peripheral hospitals and therefore 
not included in this study. The population studied is therefore a specialized population and the 
true applicability of the results may be limited to a smaller subset of the general population 
due to this selection bias. There are most likely few places in Tanzania that have similar 
populations to the one studied here. However, the results can be applied to populations 
admitted to tertiary hospitals in other major cities in Sub-Saharan Africa with comparable 
levels of malaria transmission.  
 
The time delay between data collection in 2009 and the publication of the first paper in 2013 
is another weakness of this study (especially Paper I). Malaria epidemiology is changing and 
should therefore be monitored frequently and results published promptly to increase their 
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usefulness. In addition, performing all the investigations without delay after collection, 
including RDT and PCR of whole blood and DBS, would have improved the results, as 
storage of biological material can reduce its quality depending on storage conditions and 
handling during transport. Performing the RDTs upon admission at the hospital rather than 
retrospectively may have contributed to improving the management of the patients. The RDTs 
were performed retrospectively due to considerations of funding which were not in place at 
the time of data collection. The use of the same RDT in both Papers I and II would have 
increased the comparability of these results.  
 
The choice of PCR method may be questioned, as it is a newer method that has not yet 
generally been accepted as a reference method and has been used in a limited number of 
studies. It has, however, proven to be a sensitive and specific method that was a suitable 
comparative method for this study in which we wished to also identify cases with low 
parasitemia. Other PCR assays targeting the mitochondrial genome have been used in various 
recent studies [65, 166, 167]. 
 
Including additional methods of DNA extraction from filter paper and performing several 
parallel extractions using each method on each series of dilutions in the methodological 
comparison (Paper III) would have increased the validity of the results. The greatest strength 
of the comparison in Paper III as compared to previous comparisons is the use of a 
standardized reference sample for the series of dilutions.  
 
The microscopy done retrospectively was done only on thin blood smears because they were 
available. Examining thick blood smears as well would most likely have increased the 
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sensitivity of the research microscopy and also increased the comparability to the routine 
thick blood smear results.  
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7. CONCLUSION  
Malaria remains a disease causing significant morbidity and mortality among children in Dar 
es Salaam, Tanzania. Diagnostics are challenging but the current study suggests that RDTs 
may be the best diagnostic method in clinical settings where microscopy is of low quality. 
PCR is a very sensitive and specific method for research purposes. Using DBS as a source of 
DNA for PCR circumvents some of the logistic challenges with whole blood PCR and is 
particularly useful for specimen collection in remote areas, though the sensitivity of DBS is 
lower than for whole blood. A simple Chelex-100® -based method for extraction of DNA 
from DBS appears to be a better alternative to the more expensive InstaGene™ Matrix and 
QIAamp® kit that previously have been considered better alternatives to Chelex-100®. 
Asymptomatic malaria in young children does not appear to be prevalent in the study area and 
should therefore not be considered an explanatory factor for positive malaria laboratory 
results where malaria is less suspected as cause of illness, however the generalizability of 
these results are very limited due to the many previously outlined limitations of the study on 
asymptomatic malaria.  
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8. FURTHER RECOMMENDATIONS 
1. Studies using quantitative methods should be done to identify the significance of the 
submicroscopic malaria cases which were mitochondrial Plasmodium PCR positive 
but microscopy and/or RDT negative. In addition, using a reverse transcriptase PCR 
for detecting gametocytes may identify whether submicroscopic malaria cases truly 
are caused by gametocytes as we hypothesize based on the findings in this study.    
 
2. Future studies comparing malaria diagnostics should include LAMP and ELISA 
(Enzyme-linked immunosorbent assay), as these are methods with increasing 
relevance. LAMP is especially relevant as an alternative to PCR for molecular 
diagnostics in studies in resource-poor settings.  
  
3. Larger studies of asymptomatic malaria examining various age groups, as well as 
comparing surrounding rural areas and the urban area studied in this study, should be 
performed to determine whether asymptomatic malaria truly is not prevalent in the 
study area. In addition, whole blood rather than DBS may be a better alternative as a 
source of DNA from PCR in order to identify the children with very low parasitemia 
that may not have been found using PCR of DNA from DBS. More specific questions 
about bed net use, type and quality of bed net as well as specific information about 
recent antimalarial and antibiotic use should be included in future asymptomatic 
malaria studies. 
 
4. Further studies comparing methods for DNA extraction from DBS should be done and 
include various types of filter paper stored under varying conditions for different 
durations.   
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5. Larger studies should be done to compare the sensitivity and limit of parasite detection 
of PCR on DNA extracted from DBS as compared to PCR of DNA extracted from 
whole blood as only few studies have been done on this and previous studies have 
showed more consistent results between the two methods than what was found in this 
study. 
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Errata 
Paper I: 
Page 3, Results paragraph 2, lines 5 and 6: 
The conclusion of no significant association between fatal outcome and PCR, research 
microscopy and RDT results is correct. However, the case fatality rates should be: 
20.0% for PCR, 15.0% for research microscopy and 16.7% for RDT and not the same 
numbers as given in Additional file 1 as stated.  
 
Additional File 2: 
Row two (study microscopy) under the "RDT as gold standard" heading:  
The correct numbers are Sens: 55.6%, Spec: 100.0%, False pos: 0.0%, False neg: 
44.4%.  
Row 4 (RDT) under the "study microscopy as gold standard" heading:  
The correct number are Spec: 93.3%, False pos: 6.7%.  
  
